GLP-1 Microdosing Plans
Explore low dose GLP-1 microdosing options. Some providers offer customized blends with different additives.
Patients must qualify for customized medication.Dosing may be different.Compounded medications have not been approved by the FDA; have not been reviewed by the FDA for safety, effectiveness, or quality; and have not been demonstrated to the FDA to be safe or effective for their intended use. FDA-approved medicines containing semaglutide or tirzepatide are available.Microdosing programs may have different diagnostic requirements depending on the prescribing clinician. Microdosing GLP-1 medication may not have the same health benefits as FDA-approved medication at therapeutic doses. Most GLP-1 research has been conducted with full therapeutic doses, FDA-approved medication, and patient populations with obesity or diabetes. Just because a health benefit has been observed under those conditions doesn't mean it will have the same health benefits with microdoses and patients with different diagnostic criteria.